Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.28 - $0.48 $26 - $45
-94 Reduced 0.75%
12,396 $4,000
Q3 2023

Nov 14, 2023

BUY
$0.44 - $0.63 $0 - $0
1 Added 0.01%
12,490 $5,000
Q2 2023

Aug 14, 2023

SELL
$0.31 - $0.5 $34 - $56
-112 Reduced 0.89%
12,489 $6,000
Q1 2023

May 09, 2023

SELL
$0.38 - $0.73 $930 - $1,787
-2,448 Reduced 16.27%
12,601 $5,000
Q4 2022

Feb 10, 2023

BUY
$0.55 - $26.0 $5,164 - $244,140
9,390 Added 165.93%
15,049 $10,000
Q3 2022

Nov 10, 2022

BUY
$0.08 - $26.4 $272 - $89,892
3,405 Added 151.06%
5,659 $7,000
Q2 2022

Aug 15, 2022

BUY
$16.52 - $27.0 $37,236 - $60,858
2,254 New
2,254 $2,000
Q1 2022

May 12, 2022

SELL
$19.4 - $35.8 $570,069 - $1.05 Million
-29,385 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$28.8 - $112.0 $793,468 - $3.09 Million
27,551 Added 1502.24%
29,385 $52,000
Q3 2021

Nov 15, 2021

BUY
$54.8 - $71.2 $100,503 - $130,580
1,834 New
1,834 $6,000

About Pasithea Therapeutics Corp.


  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $75.8M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.